BLLN Stock Analysis: Buy, Sell, or Hold?
$138.60
-0.99 (-0.71%)
▼
5d:
+9.93%
30d:
+13.3%
90d:
+84.68%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
1d
Get Alerted When BLLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLLN is fairly valued with market pricing in 2.5% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: BLLN is fairly valued with market pricing in 2.5% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.55
Based on 11.2% avg growth
INTRINSIC VALUE TODAY
$27.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLLN is currently trading at $138.60, which is considered extended relative to its 30-day fair value range of $118.43 to $132.59. The stock's valuation (Forward PE: 134.6) is in line with its historical norms (124.8). At these levels, the market is pricing in 2.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BLLN is in a strong uptrend. The price is approaching resistance at $140.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (15th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $123.86. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLLN is in a strong uptrend. The price is approaching resistance at $140.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (15th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $123.86. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$118.43 -
$132.59
Company Quality Score
54/100
(HOLD)
Options IV Signal
15th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
53.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 15th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 10.6% above Wall St target ($123.86)
- NEUTRAL: Market pricing in 2.5% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$118.43 -
$132.59
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$14.84
(10.7%)
Support & Resistance Levels
Support Level
$122.17
Resistance Level
$140.21
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
134.56
Wall Street Target
$123.86
(-10.6%)
Revenue Growth (YoY)
83.8%
Profit Margin
7.0%
Valuation Premium vs History
+2.5% premium
PE vs Historical
134.6 vs 124.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.5%
(market-implied from PE analysis)
1-Year Target
$142.06
(+3%)
2-Year Target
$145.62
(+5%)
3-Year Target
$149.26
(+8%)
3-Yr Target (if PE normalizes)
(PE: 135→125)
PE COMPRESSION
$138.43
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 134.6, Growth: 18.4%)
$229.99
(+66%)
Base:
(SPY PE: 20.7, Growth: 18.4%)
$35.43
(-74%)
Bear:
(PE: 17.6, Growth: 18.4%)
$30.12
(-78%)
Share & Embed Analysis
Last updated: August 02, 2026 11:51 PM ET
Data refreshes hourly during market hours. Next update: 12:51 AM
Data refreshes hourly during market hours. Next update: 12:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |